Discordance in the presumptive etiologic diagnosis and amyloid burden by ethnoracial status

Abstract

Background: In early and preclinical Alzheimer's disease AD clinical trials, amyloid biomarker criteria have resulted in differential ineligibility among racial and ethnic groups. We sought to quantify differences in PET‐derived amyloid levels across racial and ethnic groups of similar clinical diagnosis and presumed disease etiology.

The paper